PDS Biotechnology Corp Property, Plant and Equipment, Gross
PDS Biotechnology Corp (PDSB) had Property, Plant and Equipment, Gross of $295.91 thousand as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-03-30
- 2025-12-31: Property, Plant and Equipment, Gross $295.91K.
- 2024-12-31: Property, Plant and Equipment, Gross $295.91K.
- 2023-12-31: Property, Plant and Equipment, Gross $266.91K.
- 2022-12-31: Property, Plant and Equipment, Gross $115.42K.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2025-12-31 | $295.91K 10-K · filed 2026-03-30 | |
| 2024-12-31 | $295.91K 10-K · filed 2026-03-30 | |
| 2023-12-31 | $266.91K 10-K · filed 2025-03-27 | |
| 2022-12-31 | $115.42K 10-K · filed 2024-03-28 | |
| 2021-12-31 | $115.42K 10-K · filed 2023-03-28 | |
| 2020-12-31 | $115.42K 10-K · filed 2022-03-31 | |
| 2019-12-31 | $115.42K 10-K · filed 2021-03-18 | |
| 2018-12-31 | $101.80K 10-K · filed 2020-03-27 | $878.62K 10-K · filed 2019-02-21 |
| 2017-12-31 | $3.73M 10-K · filed 2019-02-21 | |
| 2016-12-31 | $3.54M 10-K · filed 2018-03-01 | |
| 2015-12-31 | $2.86M 10-K · filed 2017-03-02 | |
| 2014-12-31 | $1.48M 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |